The Drug Technical Advisory Board (DTAB) has advised the Government
to revoke the suspension of the diabetes drug pioglitazone.
The DTAB met on
July 19 and recommended that pioglitazone be put back in the market in India
The
DTAB is an advisory body and the government may or may not accept its advice
but it is likely that the recommendations may be accepted.
No comments:
Post a Comment